SCHEMBL17636893

SCHEMBL17636893

N#Cc1ccc(-c2nnc(-c3ccc(C#N)cc3)n2-c2ccc3c4ccccc4n(-c4cccc(-n5c6ccccc6c6ccccc65)c4)c3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 2/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ATM Q13315 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 2/20 0.37
PDPK1 O15530 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
USP14 P54578 1/20 0.35
MAT2A P31153 1/20 0.35
HIF1A Q16665 1/20 0.35
PTGER4 P35408 2/20 0.35
USP2 O75604 1/20 0.34
RPS6KB1 P23443 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17636891 0.96 MAPK1 (0.46) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636823 0.93 HPGD (0.47) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636884 0.91 MAPK1 (0.45) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636819 0.88 MAPK1 (0.43) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636696 0.87 MAPK1 (0.42) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636648 0.86 KDM4E (0.49) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636876 0.85 SMN1; SMN2 (0.41) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL17636877 0.85 SMN1; SMN2 (0.41) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL18347480 0.85 ATM (0.45) SMN1; SMN2LMNAMAPK1HPGDALDH1A1
SCHEMBL18347498 0.84 ATM (0.46) ATMMEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 SMN1; SMN2 3082/4885LMNA 1067/4885MAPK1 1383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.